Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

DFNS earnings analysis

Filed August 18, 2026 · Our reading of the company's report

The latest report

The supplied 10-Q extract does not include the income statement, balance sheet, cash-flow statement, segment results, or MD&A, so revenue, margins, EPS, liquidity, and free-cash-flow trends cannot be assessed. Controls…

Read full summary

The supplied 10-Q extract does not include the income statement, balance sheet, cash-flow statement, segment results, or MD&A, so revenue, margins, EPS, liquidity, and free-cash-flow trends cannot be assessed. Controls were deemed effective as of June 30, 2026, but the company disclosed success-fee litigation and the CFO’s planned resignation effective September 10, 2026. No quantitative guidance was provided, and Item 1A states “None” for risk factors.

Read the original on SEC.gov

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Aug 2022 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

What stood out

  • Disclosure controls deemed effective

    Management concluded that disclosure controls and procedures were effective as of June 30, 2026.

  • No material control changes

    The company reported no changes in internal control over financial reporting during the three months ended June 30, 2026 that materially affected, or were reasonably likely to materially affect, those controls.

What to watch

  • Success-fee litigation

    Kingswood Capital Partners filed a summons and complaint dated February 24, 2026 alleging that an investment-banking success fee is due. The company denies the allegations; a mediation assessment conference is scheduled for September 22, 2026.

  • CFO resignation

    Chief Financial Officer Roy Cohen announced on August 11, 2026 that he will resign effective September 10, 2026, creating near-term finance leadership transition risk.

  • No formal risk-factor update

    The filing's Item 1A Risk Factors section states “None,” so no new formal risk-factor updates were identified versus the prior filing; however, the litigation and CFO departure disclosed elsewhere remain material operating risks.

Management's outlook

The supplied 10-Q extract contains no quantitative revenue, EPS, margin, cash-flow, capital-spending, or forward outlook guidance. No numeric fields are provided.

Earlier filings 4

10-Q · May 20, 2026

In its Q4 2026 results, T3 Defense Inc. reported revenues of $3,653,000, marking a significant recovery from zero revenue in the prior year, but incurred a net loss of $26,351,000 compared to a net income of…

10-K · April 9, 2026

T3 Defense (DFNS) has pivoted from fintech to an aerospace & defense roll-up strategy after CEO Menachem Shalom’s September 2024 appointment, completing the Star 26 acquisition on January 12, 2026 and adding multiple…

10-Q · August 14, 2025

Nukkleus reported GAAP net income of $3,018,589 for Q2 2025 (six months net income $105,976,728) driven primarily by a non-cash fair value gain on stock purchase warrants of $109,405,811 for the six months.…

10-Q · May 23, 2025

Nukkleus reported zero revenue for the quarter and an operating loss of $1,507,107, but recorded a $104,278,287 non‑cash gain from remeasurement of stock purchase warrant liabilities that produced net income of…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.